A-A-54181
7 June 1990
COMMERCIAL ITEM DESCRIPTION
FLUNISOLIDE NASAL SOLUTION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be Flunisolide Nasal Solution, USP.
Shall be in accordance with the requirements of the USP.
Shall contain 0.25 mg per ml of flunisolide within the applicable assay limits of the solution.
Shall deliver not less than 200 metered doses.
Materials used in manufacture of the solution shall be of pharmaceutical grade.
Workmanship. The solution shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied in a bottle containing 25 mg of solution. One package containing one bottle, accompanied by a pump unit, a nasal adapter with dust cover and a patient instruction sheet, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business